Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers

Hung-Cheng Lai; Rui-Lan Huang

Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers

Research output: Contribution to journal › Article › peer-review

Abstract

The disclosure provides methylome analysis using DNA methylation biomarkers for predicting ovarian cancer prognosis and detecting malignant ovarian cancer. Being independent prognostic factors for patients with current treatment protocols, these DNA methylations are also important biomarkers for treating patients with individualized medicine in future including using chemotherapy, especially the demethylation agents or other epigenetic drugs.

Original language	Chinese (Traditional)
Journal	US Patent App
Publication status	Published - Mar 7 2013
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{9247acead19741b8b7e4a730cf23d6a5,

title = "Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers",

abstract = "The disclosure provides methylome analysis using DNA methylation biomarkers for predicting ovarian cancer prognosis and detecting malignant ovarian cancer. Being independent prognostic factors for patients with current treatment protocols, these DNA methylations are also important biomarkers for treating patients with individualized medicine in future including using chemotherapy, especially the demethylation agents or other epigenetic drugs.",

author = "Hung-Cheng Lai and Rui-Lan Huang",

year = "2013",

month = mar,

day = "7",

language = "中文",

journal = "US Patent App",

}

TY - JOUR

T1 - Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers

AU - Lai, Hung-Cheng

AU - Huang, Rui-Lan

PY - 2013/3/7

Y1 - 2013/3/7

N2 - The disclosure provides methylome analysis using DNA methylation biomarkers for predicting ovarian cancer prognosis and detecting malignant ovarian cancer. Being independent prognostic factors for patients with current treatment protocols, these DNA methylations are also important biomarkers for treating patients with individualized medicine in future including using chemotherapy, especially the demethylation agents or other epigenetic drugs.

AB - The disclosure provides methylome analysis using DNA methylation biomarkers for predicting ovarian cancer prognosis and detecting malignant ovarian cancer. Being independent prognostic factors for patients with current treatment protocols, these DNA methylations are also important biomarkers for treating patients with individualized medicine in future including using chemotherapy, especially the demethylation agents or other epigenetic drugs.

UR - https://www.google.com/patents/WO2013033333A1?cl=en

M3 - 文章

JO - US Patent App

JF - US Patent App

ER -

Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers

Abstract

UN SDGs

Other files and links

Cite this